Results 201 to 210 of about 3,994,896 (409)
A novel methodology to characterize beat-to-beat alternations in whole-cell calcium currents. [PDF]
Marimon X +3 more
europepmc +1 more source
Effect of a new calcium cyclophosphate on the demineralization of enamel: in vitro study
Geórgia Rondó [UNESP] Peres
openalex +1 more source
Diseases associated with calcium-sensing receptor [PDF]
Claire Vahé +6 more
openalex +1 more source
Automatic Neuron Detection in Calcium Imaging Data Using Convolutional Networks
Calcium imaging is an important technique for monitoring the activity of thousands of neurons simultaneously. As calcium imaging datasets grow in size, automated detection of individual neurons is becoming important.
Aguilar, Rob E. +6 more
core
Combining PTEN protein assessment and transcriptomic profiling of prostate tumors, we uncovered a network enriched in senescence and extracellular matrix (ECM) programs associated with PTEN loss and conserved in a mouse model. We show that PTEN‐deficient cells trigger paracrine remodeling of the surrounding stroma and this information could help ...
Ivana Rondon‐Lorefice +16 more
wiley +1 more source
Severe Hypocalcemia in Hungry Bone Syndrome After Parathyroid Surgery: A Case Study and Review. [PDF]
Matuszewski W +5 more
europepmc +1 more source
Potential therapeutic targeting of BKCa channels in glioblastoma treatment
This review summarizes current insights into the role of BKCa and mitoBKCa channels in glioblastoma biology, their potential classification as oncochannels, and the emerging pharmacological strategies targeting these channels, emphasizing the translational challenges in developing BKCa‐directed therapies for glioblastoma treatment.
Kamila Maliszewska‐Olejniczak +4 more
wiley +1 more source
Mitochondrial and endoplasmic reticulum calcium homeostasis and cell death.
Saverio Marchi +7 more
semanticscholar +1 more source
Effective therapeutic targeting of CTNNB1‐mutant hepatoblastoma with WNTinib
WNTinib, a Wnt/CTNNB1 inhibitor, was tested in hepatoblastoma (HB) experimental models. It delayed tumor growth and improved survival in CTNNB1‐mutant in vivo models. In organoids, WNTinib outperformed cisplatin and showed enhanced efficacy in combination therapy, supporting its potential as a targeted treatment for CTNNB1‐mutated HB.
Ugne Balaseviciute +17 more
wiley +1 more source

